We used the previously established IHC method [18] to assess the protein expression of eEF1A1 in prostate cancer tissues with Gleason 4–6 (grade group I, low risk) and Gleason 7–8 (grade group II–IV, intermediate to high risk). The gene discussed is EEF1A1; the disease is Familial prostate cancer.